Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed merger of Anchiano Therapeutics Ltd. (NasdaqGS: ANCN) with Chemomab Ltd. pursuant to which Anchiano shareholders will end up owning only approximately 10% of the combined company, prior to additional PIPE financing. KSF is seeking to determine whether the merger and the process that led to it are adequate, or whether the merger undervalues the Company.
If you believe that this transaction undervalues the Company and/or if you would like to discuss your legal rights regarding the proposed sale, you may, without obligation or cost to you, e-mail or call KSF Managing Partner Lewis S. Kahn (
[email protected]
) toll free at any time at 855-768-1857, or visit
https://www.ksfcounsel.com/cases/nasdaqgs-ancn/
to learn more.
To learn more about KSF, whose partners include the Former Louisiana Attorney General, visit
www.ksfcounsel.com
.
Kahn Swick & Foti, LLC
1100 Poydras St., Suite 3200
New Orleans, LA 70163
View source version on businesswire.com:
https://www.businesswire.com/news/home/20210116005019/en/
Contacts
Kahn Swick & Foti, LLC
Lewis S. Kahn, Managing Partner
[email protected]
855-768-1857
The post
ANCHIANO INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Anchiano Therapeutics Ltd. – ANCN
first appeared on
Financial Buzz
.
For further details see: